Bio Protocol
banner
bioprotocol.bsky.social
Bio Protocol
@bioprotocol.bsky.social
54 followers 11 following 230 posts
Biotech's new financial layer. Coin your science on Bio Protocol. Fund your research now → bio.xyz/scientists
Posts Media Videos Starter Packs
Struggling to raise for your science?

Join us next THURSDAY for a livestream exploring how Bio is helping researchers fund and accelerate their work with James Sinka, Bio's Chief Science Officer & Ethan Perlstein, Founder of Curetopia.
Researchers can now fund, develop and disseminate their science more efficiently through Bio.

➛ User-friendly tools to fund, coordinate & commercialize your research
➛ End-to-end blockchain logistics, so you can focus on science
➛ Access to a global network of investors & early adopters
For researchers, this is what becomes possible with fast access to capital, minimal overhead, a direct path from discovery to clinic, and transparent IP ownership.

If you are building in science, start here: www.bio.xyz/scientists
Launch With Bio
Bio Protocol is your dedicated partner in a journey of scientific collaboration and funding. All you need is a vision and scientific expertise.
www.bio.xyz
Bio made it possible to protect discoveries and involve patients directly.

IP stays in the hands of families through anti-shelving provisions, with 120+ rare disease groups connected via CombinedBRAIN.
The AARS2 rare disease program shows what happens when science becomes lean and transparent.

Two new drug targets discovered for under $100K in total research costs, completed within months.

Both targets are now minted as IP-NFTs, and next-generation drug screenings are underway.
• $1.8M raised in February 2025
• Ten new drug screens completed
• IP-NFTs minted and patents filed
• N-of-1 clinical studies now launching

“Very excited to have converted that 100K into several clinical candidates,” said Dr. Perlstein at DeSci Berlin.
In traditional science, years often pass between an idea and the first experiment.

With Curetopia, Ethan is proving how Bio enables faster funding, leaner operations, and parallel progress across several clinical programs.
From Harvard labs to FDA Phase 3 trials, Dr. Ethan Perlstein is proving what happens when science moves onchain.

He is using Bio to systematically attack over 10,000 rare diseases with efficiency the old system could never reach.

The new era of scientific progress 🧵
Bio Ecosystem Science Updates 🔬

From clinical studies to real-world pilots, Bio's pipeline of research projects is rapidly advancing.

Track scientific progress across decentralized biotechs in the Bio Network → www.linkedin.com/pulse/you-we...
You were not ready for this phase of science.
Trials, pilots, and research are now happening in months. Bio's pipeline of research projects is rapidly advancing.
www.linkedin.com
Last week in the Biosphere:

• VitaSTEM, the 1st Aubrai IP Token, shows how humans + AI Agents can co-drive R&D

• Men’s Health BioAgent D1ckGPT launches w/ Thailand-based doctors

• Aubrai hits funding milestone

• BioXP revamp underway

Read the full weekly report ➡️ www.bio.xyz/blog-posts/b...
Bio Weekly: Stem Cell Rejuvenation, BioAgent for Men's Health, BioXP Upgrades • BIO Resources
www.bio.xyz
How Bio works in a nutshell 🧪

Send this to your normie friends.
2 weeks left to enter the Aubrai Hypothesis Challenge

Offering up to $100K in research funding for the best longevity hypotheses selected by @aubreydegrey.bsky.social's lab & VitaDAO.

→ Learn how to use Aubrai to submit a hypothesis and qualify for research funding: aubr.ai/hypothesis-c...
September was a big month in the Bio Ecosystem 🌐

> $6.9M raise anchored by MaelstromFund
> BiomeAI & edmt Ignition Sales
> Aubrai advances hypotheses to in vitro interventions
> DeSci Seoul + Singapore
> New BioAgents & IPTs on-deck

Read the full monthly report: www.bio.xyz/blog-posts/b...
Bio Monthly: $6.9M Raise, Ignition Sales Heat Up, BioAgent to In Vitro Experiments & DeSci Singapore • BIO Resources
Highlights from September in the Bio Ecosystem include the $6.9M raise anchored by Arthur Hayes, Ignition Sales and DeSci Singapore.
www.bio.xyz
> Aubrai, the first BioAgent, recently crossed $275K in monthly research funding generated from market-making fees in the $AUBRAI token. Funding is directed to the lab of Dr. @aubreydegrey.bsky.social and its ongoing RMR2 Life Extension study feeding data into the agent.

+ much more!
Big week in the Biosphere ⚗️

> New Ignition Sales:

1) BiomeAI: a BioAgent for personalized microbiome health & trials

2) eDMT: an IP-Token exploring natural DMT production in the brain developed in partnership with a University of Florida lab
Know someone who might be interested in submitting a research proposal? They could be student, medical professional or independent researcher.

Pass along this opportunity, have them reference you in the form below, and if their hypothesis is selected, you get paid 20K $BIO tokens.
► Use Aubrai on X to create and refine a longevity hypothesis
► Best hypotheses are selected by @aubreydegrey.bsky.social and qualify for up to $100K in funding
► 20K $BIO bounty for referring researchers whose hypotheses get selected
Longevity Hypothesis Challenge 💥

Are you a researcher or big-brained longevity enthusiast?

Submit hypotheses to Aubrai on X (@Aubrai_) to qualify for up to $100K in research funding 🧵
Last week in the Biosphere 🌐

> IP Tokens coming to Bio V2
> Ignition Sale next week for $BIO + BioXP holders
> Vibe science w/ Aubrai
> $100K Longevity Hypothesis Challenge
> BioXP drop & updates
> VitaDAO proposes funding for FOXO3 gene

📖 Read the full weekly update: www.bio.xyz/blog-posts/b...
Bio Weekly: IP Token Ignition, Vibe Science, FOXO3 Gene Funding, $100K Longevity Challenge • BIO Resources
This week’s highlights: IP Token Ignition, Vibe Science with Aubrai and $100K Longevity Hypothesis Challenge.
www.bio.xyz
Vibe Science Session 👾

Join @aubreydegrey.bsky.social and VitaDAO researchers TODAY for a live 'Vibe Science' demo of the Aubrai terminal.

See hypotheses built, agent-to-lab workflows & get updates on the RMR2 study feeding data into the agent.

RSVP now: luma.com/aubraidemo
Aubrai Agent Live Demo & RMR2 Study Updates · Luma
Join us this FRIDAY for a special live demo of the Aubrai Chat Terminal! We'll be joined by Aubrey de Grey and fellow researchers as they demo Aubrai and walk…
luma.com